SITC Acute Leukemia Immunotherapy Guideline

The Society for Immunotherapy of Cancer (SITC) published it's first clinical practice guideline (CPG) on immunotherapy for the treatment of Acute Leukemia in the Journal for ImmunoTherapy of Cancer on October 19, 2020.

SITC's Cancer Immunotherapy Guidelines program is a collection of CPGs developed by multi-disciplinary panels of experts who draw from their own practical experience as well as evidence in the published literature and clinical trial data to develop evidence- and consensus-based recommendations. SITC uses as a model the Institute of Medicine's 2011 "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure the recommendations are unbiased, transparent and balanced will aid oncologists in effective clinical decision-making concerning patient selection, toxicity management, response evaluation, and the sequencing or combination of therapies, among other topics.

This Acute Leukemia CPG was developed collaboratively through the efforts of an expert panel that convened to discuss the current therapeutic landscape and covers FDA-approved immunotherapies for acute lymphoblastic and acute myeloid leukemia, as well as discussion of promising emerging treatment modalities, and patient quality of life issues.

Published Guideline

Published October 19, 2020 in the Journal for ImmunoTherapy of Cancer (JITC) as "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on Immunotherapy for the treatment of acute leukemia"

READ GUIDELINE

Webinar Series

SITC is pleased to offer free live and on-demand webinars featuring Expert Panel members from SITC's Acute Leukemia Guideline. These educational offerings are designed for healthcare providers who treat cancer patients including oncologists, hematologists, physicians, disease specialists, registered nurses, nurse practitioners, pharmacists and physician assistants. The live webinars include a dedicated question-and-answer session providing the opportunity for attendees to converse with the faculty and ask questions about the guideline recommendations.

SITC Clinical Practice Guideline Webinar – Immunotherapy for the Treatment of Acute Leukemia
SITC hosted this session on January 11, 2021 - VIEW ON-DEMAND

In this introductory webinar, Expert Panel members provide attendees with an overview of the published guideline and highlight selected recommendations that are applicable to some of the most common scenarios clinicians may encounter while treating their patients with immunotherapy. After attending this webinar, learners will be better able to implement immunotherapy treatments effectively and in accordance with the recommendations in the SITC CPG.

Practical Management Pearls for Immunotherapy for the Treatment of Acute Leukemia – SITC CPG Webinar
Thursday, October 14, 2021, 11:30 a.m. to 12:30 p.m. EDT - REGISTER NOW

This advanced webinar is designed so that attendees will know how to appraise and classify organ-specific considerations for immunotherapy agents and toxicities, identify and manage clinically significant uncommon toxicities, and determine optimal sequencing of immunotherapies in relapsed and/or refractory disease.This webinar is not accredited.

Case Studies in Immunotherapy for the Treatment of Acute Leukemia – SITC CPG Webinar
Monday, November 15, 2021, 11:30 a.m. to 12:30 p.m. EDT - REGISTER NOW

Faculty will engage attendees through a combination of case presentations with a “virtual tumor board” discussion and Q&A with diverse sub-specialty experts based on the needs of each particular case. This high-level webinar is designed so attendees will be able to execute the use of immunotherapy with increased confidence, plan management strategies for difficult cases, and identify and discuss areas of controversy in the immunotherapy field. This webinar is not accredited.